Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease

Genome Biology

Volumn 16, Issue 1, 2015, Pages

  Morgan, Xochitl C ^a,b   Kabakchiev, Boyko ^c   Waldron, Levi ^a,d   Tyler, Andrea D ^c   Tickle, Timothy L ^a,b   Milgrom, Raquel ^c   Stempak, Joanne M ^c   Gevers, Dirk ^b   Xavier, Ramnik J ^b   Silverberg, Mark S ^c   Huttenhower, Curtis ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; INTERLEUKIN 12; METRONIDAZOLE; RNA 16S; TRANSCRIPTOME; VANCOMYCIN;

ADULT; AGED; AKKERMANSIA; ARTICLE; BACTERIUM; BIFIDOBACTERIUM; CLADISTICS; CONTROLLED STUDY; DRUG USE; ESCHERICHIA; FAMILIAL COLON POLYPOSIS; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HOST; HOST PATHOGEN INTERACTION; HUMAN; HUMAN TISSUE; ILEAL POUCH ANAL ANASTOMOSIS; ILEITIS; ILEUM POUCH; INFLAMMATORY BOWEL DISEASE; INTESTINE ANASTOMOSIS; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MICROBIAL COMMUNITY; NONHUMAN; POPULATION ABUNDANCE; PRE POUCH ILEUM; PRINCIPAL COMPONENT ANALYSIS; RNA SEQUENCE; ROSEBURIA; SUTTERELLA; TISSUE DISTRIBUTION; TRANSCRIPTOMICS; ULCERATIVE COLITIS; ADOLESCENT; COHORT ANALYSIS; COLOSTOMY BAG; DNA SEQUENCE; GASTROINTESTINAL TRACT; GENE EXPRESSION PROFILING; GENETICS; INFLAMMATORY BOWEL DISEASES; ISOLATION AND PURIFICATION; MICROARRAY ANALYSIS; MICROBIOLOGY; MIDDLE AGED; MUCOSA; MULTIVARIATE ANALYSIS; PATHOLOGY; YOUNG ADULT;

AKKERMANSIA; ESCHERICHIA; ROSEBURIA; SUTTERELLA;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; COLITIS, ULCERATIVE; COLONIC POUCHES; FEMALE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MUCOUS MEMBRANE; MULTIVARIATE ANALYSIS; POUCHITIS; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84938612863     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/s13059-015-0637-x     Document Type: Article

References (74)

1. Landy J, Al-Hassi HO, McLaughlin SD, Knight SC, Ciclitira PJ, Nicholls RJ, et al. Etiology of pouchitis. Inflamm Bowel Dis. 2012;18:1146-55.
2. Tyler AD, Milgrom R, Stempak JM, Xu W, Brumell JH, Muise AM, et al. The NOD2insC polymorphism is associated with worse outcome following ileal pouch-anal anastomosis for ulcerative colitis. Gut. 2013;62:1433-9.
3. McLaughlin SD, Clark SK, Tekkis PP, Nicholls RJ, Ciclitira PJ. The bacterial pathogenesis and treatment of pouchitis. Therap Adv Gastroenterol. 2010;3:335-48.
4. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119-24.
5. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13:R79.
6. Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, Yantiss R, et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. Isme J. 2007;1:403-18.
7. Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut. 2011;60:631-7.
8. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Folsch UR, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53:685-93.
9. Tyler AD, Knox N, Kabakchiev B, Milgrom R, Kirsch R, Cohen Z, et al. Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosis. PLoS One. 2013;8:e66934.
10. Khan KJ, Ullman TA, Ford AC, Abreu MT, Abadir A, Marshall JK, et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2011;106:661-73.
11. Wang SL, Wang ZR, Yang CQ. Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease. Exp Ther Med. 2012;4:1051-6.
12. Wu H, Shen B. Pouchitis: lessons for inflammatory bowel disease. Curr Opin Gastroenterol. 2009;25:314-22.
13. de Silva HJ, Millard PR, Kettlewell M, Mortensen NJ, Prince C, Jewell DP. Mucosal characteristics of pelvic ileal pouches. Gut. 1991;32:61-5.
14. Young VB, Raffals LH, Huse SM, Vital M, Dai D, Schloss PD, et al. Multiphasic analysis of the temporal development of the distal gut microbiota in patients following ileal pouch anal anastomosis. Microbiome. 2013;1:9.
15. McLaughlin SD, Walker AW, Churcher C, Clark SK, Tekkis PP, Johnson MW, et al. The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann Surg. 2010;252:90-8.
16. Zella GC, Hait EJ, Glavan T, Gevers D, Ward DV, Kitts CL, et al. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm Bowel Dis. 2011;17:1092-100.
17. Kabakchiev B, Tyler A, Stempak JM, Milgrom R, Silverberg MS. Downregulation of expression of xenobiotic efflux genes is associated with pelvic pouch inflammation in ulcerative colitis. Inflamm Bowel Dis. 2014;20:1157-64.
18. Ben-Shachar S, Yanai H, Baram L, Elad H, Meirovithz E, Ofer A, et al. Gene expression profiles of ileal inflammatory bowel disease correlate with disease phenotype and advance understanding of its immunopathogenesis. Inflamm Bowel Dis. 2013;19:2509-21.
19. Ringner M. What is principal component analysis? Nat Biotech. 2008;26:303-4.
20. Alter O, Brown PO, Botstein D. Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci U S A. 2000;97:10101-6.
21. Biswas S, Storey JD, Akey JM. Mapping gene expression quantitative trait loci by singular value decomposition and independent component analysis. BMC Bioinformatics. 2008;9:244.
22. Dyer MD, Neff C, Dufford M, Rivera CG, Shattuck D, Bassaganya-Riera J, et al. The human-bacterial pathogen protein interaction networks of Bacillus anthracis, Francisella tularensis, and Yersinia pestis. PLoS One. 2010;5, e12089.
23. Breadcrumbs. [ http://huttenhower.sph.harvard.edu/biobakery/breadcrumbs ].
24. Nagy E, Foldes J. Inactivation of metronidazole by Enterococcus faecalis. J Antimicrob Chemother. 1991;27:63-70.
25. Perry JD, Ford M, Gould FK. Susceptibility of enterococci to ciprofloxacin. J Antimicrob Chemother. 1994;34:297-8.
26. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics. 2009;10:48.
27. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60.
28. MaAsLiN. [ http://huttenhower.sph.harvard.edu/maaslin ].
29. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110:9066-71.
30. Williams BL, Hornig M, Parekh T, Lipkin WI. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. mBio. 2012;3:e00261-11.
31. Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA. Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder. Mol Autism. 2013;4:42.
32. Gevers D, Kugathasan S, Denson LA, Vazquez-Baeza Y, Van Treuren W, Ren B, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe. 2014;15:382-92.
33. Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207-14.
34. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59-65.
35. Yasuda K, Oh K, Ren B, Tickle TL, Franzosa EA, Wachtman LM, et al. Biogeography of the intestinal mucosal and lumenal microbiome in the rhesus macaque. Cell Host Microbe. 2015;17:385-91.
36. Sharon I, Morowitz MJ, Thomas BC, Costello EK, Relman DA, Banfield JF. Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization. Genome Res. 2013;23:111-20.
37. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A. 2011;108:4578-85.
38. Makino H, Kushiro A, Ishikawa E, Kubota H, Gawad A, Sakai T, et al. Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant's microbiota. PLoS One. 2013;8:e78331.
39. Kostic AD, Gevers D, Siljander H, Vatanen T, Hyotylainen T, Hamalainen AM, et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe. 2015;17:260-73.
40. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559-63.
41. Lofmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis. 2010;50:S16-23.
42. Sheng WS, Hsueh PR, Hung CC, Teng LJ, Chen YC, Luh KT. Clinical features of patients with invasive Eikenella corrodens infections and microbiological characteristics of the causative isolates. Eur J Clin Microbiol Infect Dis. 2001;20:231-6.
43. Lubbe MM, Stanley K, Chalkley LJ. Prevalence of nim genes in anaerobic/facultative anaerobic bacteria isolated in South Africa. FEMS Microbiol Lett. 1999;172:79-83.
44. de Been M, van Schaik W, Cheng L, Corander J, Willems RJ. Recent recombination events in the core genome are associated with adaptive evolution in Enterococcus faecium. Genome Biol Evol. 2013;5:1524-35.
45. Rams TE, Feik D, Mortensen JE, Degener JE, van Winkelhoff AJ. Antibiotic susceptibility of periodontal Enterococcus faecalis. J Periodontol. 2013;84:1026-33.
46. Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis. 1998;26:1127-33.
47. Rafii F, Wynne R, Heinze TM, Paine DD. Mechanism of metronidazole-resistance by isolates of nitroreductase-producing Enterococcus gallinarum and Enterococcus casseliflavus from the human intestinal tract. FEMS Microbiol Lett. 2003;225:195-200.
48. Jia W, Li G, Wang W. Prevalence and antimicrobial resistance of Enterococcus species: a hospital-based study in China. Int J Environ Res Public Health. 2014;11:3424-42.
49. Sadowy E, Sienko A, Gawryszewska I, Bojarska A, Malinowska K, Hryniewicz W. High abundance and diversity of antimicrobial resistance determinants among early vancomycin-resistant Enterococcus faecium in Poland. Eur J Clin Microbiol Infect Dis. 2013;32:1193-203.
50. Sreeja S, Babu PRS, Prathab AG. The prevalence and the characterization of the enterococcus species from various clinical samples in a tertiary care hospital. J Clin Diagn Res. 2012;6:1486-8.
51. Gutierrez Martin CB, Rodriguez Ferri EF. In vitro susceptibility of Pasteurella multocida subspecies multocida strains isolated from swine to 42 antimicrobial agents. Zentralbl Bakteriol. 1993;279:387-93.
52. Elliott TR, Hudspith BN, Wu G, Cooley M, Parkes G, Quinones B, et al. Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2326-38.
53. Winter SE, Winter MG, Xavier MN, Thiennimitr P, Poon V, Keestra AM, et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science. 2013;339:708-11.
54. Kang CS, Ban M, Choi EJ, Moon HG, Jeon JS, Kim DK, et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS One. 2013;8:e76520.
55. Ganesh BP, Klopfleisch R, Loh G, Blaut M. Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PLoS One. 2013;8:e74963.
56. Race AM, Steven RT, Palmer AD, Styles IB, Bunch J. Memory efficient principal component analysis for the dimensionality reduction of large mass spectrometry imaging data sets. Anal Chem. 2013;85:3071-8.
57. Engreitz JM, Daigle Jr BJ, Marshall JJ, Altman RB. Independent component analysis: mining microarray data for fundamental human gene expression modules. J Biomed Inform. 2010;43:932-44.
58. Korkeila EA, Sundstrom J, Pyrhonen S, Syrjanen K. Carbonic anhydrase IX, hypoxia-inducible factor-1alpha, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer: multivariate Cox survival models following data reduction by principal component analysis of the clinicopathological predictors. Anticancer Res. 2011;31:4529-35.
59. Heuschen UA, Autschbach F, Allemeyer EH, Zollinger AM, Heuschen G, Uehlein T, et al. Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis. Dis Colon Rectum. 2001;44:487-99.
60. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006;7:3.
61. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249-64.
62. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118-27.
63. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012;6:1621-4.
64. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335-6.
65. McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012;6:610-8.
66. Knights D, Kuczynski J, Koren O, Ley RE, Field D, Knight R, et al. Supervised classification of microbiota mitigates mislabeling errors. ISME J. 2011;5:570-3.
67. Knights D, Kuczynski J, Charlson ES, Zaneveld J, Mozer MC, Collman RG, et al. Bayesian community-wide culture-independent microbial source tracking. Nat Methods. 2011;8:761-3.
68. Legendre P, Gallagher E. Ecologically meaningful transformations for ordination of species data. Oecologia. 2001;129:271-80.
69. Ward JH. Hierarchical grouping to optimize an objective function. J Am Stat Assoc. 1963;58:236-44.
70. Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining, inference and prediction. 2nd ed. New York: Springer; 2009.
71. Gene Set Enrichment Analysis. [ http://www.broadinstitute.org/gsea ]
72. Pouchitis. [ https://bitbucket.org/biobakery/pouchitis-public/ ]
73. Pouchitis Source. [ https://bitbucket.org/biobakery/pouchitis-public/src ]
74. Pouchitis2015. [ http://huttenhower.sph.harvard.edu/pouchitis2015 ]